S. E. Barton, J. S. Najita, E. S. Ginsburg, W. M. Leisenring, M. Stovall et al., Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort, Lancet Oncol, vol.14, pp.873-81, 2013.

J. F. Kelvin, B. Thom, C. Benedict, J. Carter, S. Corcoran et al., Cancer and fertility program improves patient satisfaction with information received, J Clin Oncol, vol.34, pp.1780-1786, 2016.
DOI : 10.1200/jco.2015.64.5168
URL : http://europepmc.org/articles/pmc4966338?pdf=render

D. K. Mccray, A. B. Simpson, R. Flyckt, Y. Liu, C. O'rourke et al., Fertility in women of reproductive age after breast cancer treatment: practice patterns and outcomes, Ann Surg Oncol, vol.23, pp.3175-81, 2016.

W. Van-dorp, R. L. Mulder, L. C. Kremer, M. M. Hudson, M. M. Van-den-heuvel-eibrink et al., Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium, J Clin Oncol, vol.34, pp.3440-50, 2016.

A. H. Partridge, K. J. Ruddy, S. Gelber, L. Schapira, M. Abusief et al., Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer, Fertil Steril, vol.94, pp.638-682, 2010.

J. A. Petrek, M. J. Naughton, L. D. Case, E. D. Paskett, E. Z. Naftalis et al., Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study, J Clin Oncol, vol.2, pp.1045-51, 2006.

J. M. Walshe, N. Denduluri, and S. M. Swain, Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer, J Clin Oncol, vol.24, pp.5769-79, 2006.
DOI : 10.1200/jco.2006.07.2793

D. Dewailly, C. Y. Andersen, A. Balen, F. Broekmans, N. Dilaver et al., The physiology and clinical utility of antiMullerian hormone in women, Hum Reprod Update, vol.20, pp.370-85, 2014.

L. Marca, A. Stabile, G. Artenisio, A. C. Volpe, and A. , Serum antiMullerian hormone throughout the human menstrual cycle, Hum Reprod, vol.21, pp.3103-3110, 2006.

L. E. Bath, W. H. Wallace, M. P. Shaw, C. Fitzpatrick, and R. A. Anderson, Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound, Hum Reprod, vol.18, pp.2368-74, 2003.

R. D. Van-beek, M. M. Van-den-heuvel-eibrink, J. S. Laven, F. H. De-jong, A. P. Themmen et al., AntiMullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood, J Clin Endocrinol Metab, vol.92, pp.3869-74, 2007.

T. Fréour, P. Barrière, and D. Masson, Anti-Mü llerian Hormone (AMH) levels and evolution in women of reproductive age with breast cancer treated with chemotherapy, Eur J Cancer, vol.74, pp.1-8, 2017.

C. Decanter, M. Peigne, A. Mailliez, F. Morschhauser, A. Dassonneville et al., Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimullerian hormone assay, Fertil Steril, vol.102, pp.483-490, 2014.

R. A. Anderson, M. Rosendahl, T. W. Kelsey, and D. A. Cameron, Pretreatment anti-Mullerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer, Eur J Cancer, vol.49, pp.3404-3415, 2013.

R. A. Anderson, A. P. Themmen, A. Al-qahtani, N. P. Groome, and D. A. Cameron, The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer, Hum Reprod, vol.21, pp.2583-92, 2006.

A. S. Hamy, R. Porcher, C. Cuvier, S. Giacchetti, M. H. Schlageter et al., Ovarian reserve in breast cancer: assessment with anti-Mullerian hormone, Reprod Biomed Online, vol.29, pp.573-80, 2014.
DOI : 10.1016/j.rbmo.2014.07.008
URL : http://www.rbmojournal.com/article/S1472648314004143/pdf

J. Van-helden and R. Weiskirchen, Performance of the two new fully automated anti-Mullerian hormone immunoassays compared with the clinical standard assay, Hum Reprod, vol.30, 2015.

M. Hickey, M. Peate, C. M. Saunders, and M. Friedlander, Breast cancer in young women and its impact on reproductive function, Hum Reprod Update, vol.15, pp.323-362, 2009.

E. Amir, O. Freedman, L. Allen, T. Colgan, and M. Clemons, Defining ovarian failure in amenorrheic young breast cancer patients, Breast, vol.19, pp.545-553, 2010.
DOI : 10.1016/j.breast.2010.06.003

E. C. Larsen, J. Muller, C. Rechnitzer, K. Schmiegelow, and A. N. Andersen, Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l, Hum Reprod, vol.18, pp.417-439, 2003.
DOI : 10.1093/humrep/deg073
URL : https://academic.oup.com/humrep/article-pdf/18/2/417/1791411/deg073.pdf

A. G. Waks and A. H. Partridge, Fertility preservation in patients with breast cancer: necessity, methods, and safety, J Natl Compr Canc Netw, vol.14, pp.355-63, 2016.
DOI : 10.6004/jnccn.2016.0038
URL : https://jnccn.org/downloadpdf/journals/jnccn/14/3/article-p355.pdf

C. Anders, P. K. Marcom, B. Peterson, L. Gu, S. Unruhe et al., A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer, Cancer Investig, vol.26, pp.286-95, 2008.

R. A. Anderson and D. A. Cameron, Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer, J Clin Endocrinol Metab, vol.96, pp.1336-1379, 2011.
DOI : 10.1210/jc.2010-2582
URL : https://academic.oup.com/jcem/article-pdf/96/5/1336/13652418/jcem1336.pdf

J. Chai, A. F. Howie, D. A. Cameron, and R. A. Anderson, A highlysensitive anti-Mullerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer, Eur J Cancer, vol.50, pp.2367-74, 2014.

K. J. Ruddy, A. O&apos;neill, K. D. Miller, B. P. Schneider, E. Baker et al., Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103, Breast Cancer Res Treat, vol.144, pp.591-598, 2014.

H. C. Su, C. Haunschild, K. Chung, S. Komrokian, S. Boles et al., Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients, Cancer, vol.120, pp.3691-3699, 2014.

I. Ben-aharon, T. Granot, I. Meizner, N. Hasky, A. Tobar et al., Long-term follow-up of chemotherapy-induced ovarian failure in young breast cancer patients: the role of vascular toxicity, Oncologist, vol.20, pp.985-91, 2015.

B. Yu, N. Douglas, M. J. Ferin, G. S. Nakhuda, K. Crew et al., Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy, Cancer, vol.116, pp.2099-105, 2010.

F. J. Broekmans, J. Kwee, D. J. Hendriks, B. W. Mol, and C. B. Lambalk, A systematic review of tests predicting ovarian reserve and IVF outcome, Hum Reprod Update, vol.12, pp.685-718, 2006.

A. M. D&apos;avila, V. Biolchi, E. Capp, and H. Corleta, Age, anti-mullerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide, J Ovarian Res, vol.8, pp.82-89, 2015.

O. Goldrat, N. Kroman, F. A. Peccatori, O. Cordoba, B. Pistilli et al., Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome, Eur J Cancer, vol.51, pp.1490-1496, 2015.

N. Kroman, M. B. Jensen, J. Wohlfahrt, and B. Ejlertsen, Pregnancy after treatment of breast cancerea population-based study on behalf of Danish Breast Cancer Cooperative Group, Acta Oncol, vol.47, pp.545-554, 2008.

I. Streuli, J. De-mouzon, C. Paccolat, C. Chapron, P. Petignat et al., AMH concentration is not related to effective time to pregnancy in women who conceive naturally, Reprod Biomed Online, vol.28, pp.216-240, 2014.

S. M. Zarek, E. M. Mitchell, L. A. Sjaarda, S. L. Mumford, R. M. Silver et al., Is anti-Mullerian hormone associated with fecundability? Findings from the EAGeR trial, J Clin Endocrinol Metab, vol.100, pp.4215-4236, 2015.

L. Casadei, C. Manicuti, F. Puca, A. Madrigale, E. Emidi et al., Can anti-Mullerian hormone be predictive of spontaneous onset of pregnancy in women with unexplained infertility?, J Obstet Gynaecol, vol.33, pp.857-61, 2013.

H. Hamre, C. E. Kiserud, E. Ruud, P. M. Thorsby, and S. D. Fossa, Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study, Pediatr Blood Cancer, vol.59, pp.271-278, 2012.

A. S. Hamy, R. Porcher, S. Eskenazi, C. Cuvier, S. Giacchetti et al., Anti-Mullerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies, Reprod Biomed Online, vol.32, pp.299-307, 2016.

M. Depmann, M. J. Eijkemans, S. L. Broer, G. J. Scheffer, I. A. Van-rooij et al., Does anti-Mullerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study, Hum Reprod, vol.31, pp.1579-87, 2016.